The Global Preclinical CRO Market size was estimated at USD 5,379.95 million in 2022, USD 5,881.52 million in 2023, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.87% to reach USD 11,428.84 million by 2030.
The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Preclinical CRO Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.
The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Preclinical CRO Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.
Market Segmentation & Coverage:
This research report categorizes the Global Preclinical CRO Market in order to forecast the revenues and analyze trends in each of following sub-markets:- Based on Services, the market is studied across Bioanalysis and DMPK Studies and Toxicology Testing. The Toxicology Testing commanded largest market share of 47.14% in 2022, followed by Bioanalysis and DMPK Studies.
- Based on End-user, the market is studied across Biopharmaceutical Companies, Government and Academic Institutes, and Medical Device Companies. The Biopharmaceutical Companies commanded largest market share of 77.91% in 2022, followed by Government and Academic Institutes.
- Based on Application, the market is studied across Cardiovascular Diseases, Central Nervous System Disorders, Diabetes, Immunological Disorders, Infectious Diseases, Oncology, and Respiratory Diseases. The Cardiovascular Diseases commanded largest market share of 17.67% in 2022, followed by Central Nervous System Disorders.
- Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, Minnesota, New Jersey, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 36.78% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Global Preclinical CRO Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Preclinical CRO Market, including Atuka Inc., CATO SMS, Celerion, Charles River Laboratories International, Inc., Emergo, Ethica Group, Eurofins Scientific, ICON PLC, Inotiv, Inc., Laboratory Corporation of America, Inc., Medpace, Inc., PharmaCircle LLC, PPD Inc., SCiAN Services, Shanghai Medicilon Inc., Syneos Health, Inc., Syreon Corporation, Veristat LLC, Vimta Labs Limited, WuXi AppTec, Inc., and ZM Company.The report provides insights on the following pointers:
- Market Penetration: Provides comprehensive information on the market offered by the key players
- Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
- Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
- Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
- Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
- Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
- What is the market size and forecast of the Global Preclinical CRO Market?
- What are the inhibiting factors and impact of COVID-19 shaping the Global Preclinical CRO Market during the forecast period?
- Which are the products/segments/applications/areas to invest in over the forecast period in the Global Preclinical CRO Market?
- What is the competitive strategic window for opportunities in the Global Preclinical CRO Market?
- What are the technology trends and regulatory frameworks in the Global Preclinical CRO Market?
- What is the market share of the leading vendors in the Global Preclinical CRO Market?
- What modes and strategic moves are considered suitable for entering the Global Preclinical CRO Market?
Frequently Asked Questions about the Global Preclinical CRO Market
What is the estimated value of the Global Preclinical CRO Market?
What is the growth rate of the Global Preclinical CRO Market?
What is the forecasted size of the Global Preclinical CRO Market?
Who are the key companies in the Global Preclinical CRO Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 227 |
| Published | May 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 5379.95 Million |
| Forecasted Market Value ( USD | $ 11428.84 Million |
| Compound Annual Growth Rate | 9.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Preclinical CRO Market, by Services
7. Preclinical CRO Market, by End-user
8. Preclinical CRO Market, by Application
9. Americas Preclinical CRO Market
10. Asia-Pacific Preclinical CRO Market
11. Europe, Middle East & Africa Preclinical CRO Market
12. Competitive Landscape
13. Company Usability Profiles
14. Appendix
List of Figures
List of Tables
Companies Mentioned
- Atuka Inc.
- CATO SMS
- Celerion
- Charles River Laboratories International, Inc.
- Emergo
- Ethica Group
- Eurofins Scientific
- ICON PLC
- Inotiv, Inc.
- Laboratory Corporation of America, Inc.
- Medpace, Inc.
- PharmaCircle LLC
- PPD Inc.
- SCiAN Services
- Shanghai Medicilon Inc.
- Syneos Health, Inc.
- Syreon Corporation
- Veristat LLC
- Vimta Labs Limited
- WuXi AppTec, Inc.
- ZM Company
Methodology
LOADING...
